NCT04601896View on ClinicalTrials.gov

Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

October 16, 2020

Primary Completion Date

January 15, 2021

Study Completion Date

April 27, 2021

Conditions
Refractory Cardiac ArrestExtraCorporeal Membrane Oxygenation (ECMO)
Interventions
OTHER

SF36 questionnaire via telephone interview

SF36 questionnaire via telephone interview

Trial Locations (1)

38043

Chu Grenoble Alpes, Grenoble

All Listed Sponsors
lead

University Hospital, Grenoble

OTHER

NCT04601896 - Evaluation of Quality of Life and Its Influencing Factors After VA-ECMO in Refractory Cardiac Arrest Based on SF-36 Score : A Grenoble Cohort Study From 2006 Through 2018 | Biotech Hunter | Biotech Hunter